ArticleInternational journal of molecular sciences2025

Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer's Disease Phenotype in APP/PS1 Transgenic Mice.

Henry W Querfurth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.